Kwok, Charlie H. T.
Harding, Erika K.
Burma, Nicole E. http://orcid.org/0000-0001-8076-1798
Markovic, Tamara
Massaly, Nicolas
van den Hoogen, Nynke J. http://orcid.org/0000-0002-1731-2903
Stokes-Heck, Sierra http://orcid.org/0009-0005-0472-8212
Gambeta, Eder
Komarek, Kristina http://orcid.org/0000-0002-3139-3009
Yoon, Hye Jean http://orcid.org/0000-0002-3830-3678
Navis, Kathleen E.
McAllister, Brendan B. http://orcid.org/0000-0003-4135-3040
Canet-Pons, Julia
Fan, Churmy
Dalgarno, Rebecca
Gorobets, Evgueni
Papatzimas, James W. http://orcid.org/0000-0001-8944-1037
Zhang, Zizhen http://orcid.org/0000-0001-8069-3756
Kohro, Yuta http://orcid.org/0000-0002-3128-7388
Anderson, Connor L. http://orcid.org/0000-0001-8651-5221
Thompson, Roger J.
Derksen, Darren J. http://orcid.org/0000-0002-5945-6921
MorĂ³n, Jose A. http://orcid.org/0000-0003-3216-2488
Zamponi, Gerald W. http://orcid.org/0000-0002-0644-9066
Trang, Tuan http://orcid.org/0000-0003-3309-9492
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-173553, PJT-173553)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN06289-2019)
Article History
Received: 18 April 2023
Accepted: 11 July 2024
First Online: 24 July 2024
Competing interests
: T.T., D.J.D., and R.J.T. are co-founders of AphioTx Inc. Patents have been granted for the use of probenecid in opioid withdrawal (T.T., N.E.B.). Patents are pending for EG-2183 and related compounds for use in opioid withdrawal (T.T., D.J.D., C.H.T.K., E.K.H., N.E.B., E.G., K.K., K.E.N., C.F., E.G., and J.W.P. Specific patent details are provided in the Disclosure of Potential Competing Interest. G.W.Z. is co-founder and CSO of Zymedyne Therapeutics. All other authors have declared that no conflict of interest exists.